Skip to content

Author

F. Lumancas

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Cardiovascular and renal outcomes of Semaglutide in patients with Type 2 Diabetes Mellitus with established Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease: A Meta-Analysis

Type 2 diabetes mellitus (T2DM), atherosclerotic cardiovascular disease (ASCVD) and chronic kidney disease (CKD) constitute a high risk triad for major adverse cardiovascular and renal events. Semaglutide, a glucagon-like peptide-1 receptor agonist (GLP 1-RA), has emerged as an important therapeutic option....

F. Lumancas, K. Katada · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.